Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-07

Clinical Trial Update: A Study to Investigate Bio Product Laboratory Ltd (BPL's) Factor X in the Prophylaxis of Bleeding in Children <12 Years [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Factor X concentrate from Bio Products Laboratory for prophylaxis of bleeding in children under 12 with Factor X deficiency …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Factor X concentrate (Factor X concentrate)

Snippet

Sponsor: Bio Products Laboratory | Conditions: Factor X Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2018-03-07